If Drug Treatment Works So Well, Why Are So Many Drug Users in Prison?
Harold Pollack, Peter Reuter, and Eric Sevigny Drug use and drug sales play central roles in the history of American crime. One cannot discuss crime in America in the 1970s without reference to the heroin epidemic nor in the 1980s and early 1990s without reference to powder and crack cocaine. The highly punitive regime in place now for drug offenders is largely a response to the association of these epidemics with crime waves. Yet these drug epidemics unfolded a long time ago, with apparently low rates of initiation into drug dependence in recent years. From the vantage point of 2011, one might think that these drugs no longer matter much, and that dependent drug use plays a smaller role in crime and criminal justice policy than it did ten or twenty years ago. In fact, however, data from many sources (some described later) indicate that those arrested or incarcerated within the American criminal justice system remain heavily involved in the consumption of illicit drugs.
There is abundant evidence that inducing criminal offenders to halt or reduce their substance use would reduce crime. Policymakers, researchers, and advocates have long argued that broader provision of substance abuse treatment could reduce the number of Americans behind bars.
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We thank Holly Nguyen for capable research assistance. We thank Jonathan Caulkins, Steven Raphael, and the conference organizers for excellent comments. 2001 ) and there are some indicators that the decline may have continued. This would suggest that there are fewer sellers as well as fewer users to lock up.
Why has the United States achieved such limited success in getting criminal offenders to curtail their drug use? Put slightly differently, why is it so difficult to replicate at the population level the substantial reductions in drug use and criminal offending that treatment appears capable of achieving for individual offenders? Why aren't more offenders in treatment? And why have diversion programs such as California's Proposition 36 and drug courts proved relatively disappointing in achieving their stated goals?
We hypothesize that there are two main reasons for the continued large numbers of drug users fl owing into, and remaining within, the correctional system: First, eligibility criteria for diversion programs, particularly for drug courts, are restrictive. Although the various programs are effective and even cost-effective in serving the specifi c clients they recruit, they make only a small contribution at the population level. The diverted offenders are at low risk of going to prison or even jail (following sentencing, as opposed to pretrial) in the absence of the drug court intervention. Given limited capacity and the relatively low-risk populations actually served, the currently deployed model of drug courts is unlikely to notably reduce prison populations.
A second, related pattern also hinders the effectiveness of these interventions. There is a systematic mismatch between sentencing practices and actual criminal careers among drug-involved offenders. As individual criminally active drug users get older, the system increasingly treats them harshly for each successive offense. They have longer criminal histories, longer records of unsuccessful treatment, and worse employment histories. Thus, not only are they less eligible for diversion programs, these offenders also receive longer sentences, increasing the share of the incarcerated population with drug problems.
The empirical contribution of this chapter primarily concerns the fi rst of these conjectures. In particular, we examine what share of those currently incarcerated would have been eligible for drug courts with the least restrictive entry criteria. We have not been able to fi nd data that allows testing of the effect of the potentially lengthening criminal careers of dependent drug users.
To test the hypothesis about the ineffectiveness of drug courts to reduce the size of the incarcerated drug-offending population, we make use of the Survey of Inmates in State Correctional Facilities (SISCF) and the Survey of Inmates in Local Jails (SILJ), two Bureau of Justice Statistics (BJS) occasional surveys. Both provide self-reports on, inter alia, criminal activity and substance use from nationally representative samples of inmates; the Prison survey has been conducted six times between 1974 and 2004 (with federal inmates surveyed only in the 1997 and 2004 studies), while the Jail survey has been conducted six times between 1972 and 2002. We fi nd that, indeed, very few of those entering state prison in 2004 or jail in 2002 would have been eligible for diversion through state courts. That this is true for local jails is much more surprising than the prison fi nding. This pattern provides a reminder that, even late in the incarceration boom, it is not so easy to get incarcerated, conditional on arrest.
There are two reasons for the fi ndings about drug courts. First, many entering prison and jail (whether drug users or not) were on supervised release (parole or probation) at the time of their latest arrest, which automatically made them ineligible for most drug court interventions. Second, and more interestingly, most of those who were arrested de novo and who had drug use patterns making them potential clients for drug court, had long, relatively serious criminal records that would have made them ineligible under current conditions. Drug use itself may lead to more intense or longer criminal careers. Moreover, many of those dependent on expensive drugs (cocaine, crack, heroin, and methamphetamine) became drug users a long time ago. These populations are aging, which is not true of nondrugusing criminal offenders. In effect, what we are seeing is two distinct trends in the incarcerated population, separated by drug use.
We also present three other policy-relevant descriptive fi ndings: First, it is useful to compare the number of dependent drug users entering treatment with the number entering prison. Both in 1986 and 2004, these fi gures are approximately comparable; the United States is locking up about as many drug addicts as it is treating, a troubling observation about the nation's drug policies.
Second, there are indications that drug dependence is less prevalent among younger offenders than in cohorts that are twenty years older. Absent a new drug epidemic or a newly invigorated drug war, there is a predictable end in sight to the growth of drug-related prisoners.
Third, for drug using prisoners, the probability of a violent offense declines sharply with age after thirty-fi ve.
This last observation leads us to our principal policy suggestion, which needs further investigation. Diversion programs of all kinds require substantial redesign if they are to contribute to a reduction in the incarcerated population. Experienced drug users, who account for an increasing share of drug-related crime, are not attractive (or eligible) candidates for many current efforts. However, if one is willing to take a very long-term social welfare perspective, it may be worth introducing courts specifi cally designed for the long-term user. Our fi nding that aging drug users commit relatively few violent crimes is helpful here. The risks associated with treatment-oriented community supervision of older offenders are therefore less than one likely encounters in younger drug-using cohorts.
The chapter begins with three review sections. Section 3.1 describes the changing patterns of drug misuse in the United States over the last forty years, which is necessary to understand the challenge now facing the criminal justice system. Section 3.2 follows with a review of what is known about the effectiveness of drug treatment in reducing crime at the individual level. Section 3.3 briefl y discusses interventions aimed at diverting drug-involved offenders from incarceration, such as drug courts, Proposition 36 (the largest diversion program in operation, even though it is restricted to California alone), and coerced abstinence/ mandated desistence in Hawaii. Section 3.4 presents our empirical analysis of the surveys of jail and state prison inmates, showing the limited potential impact of drug courts under current eligibility rules. Section 3.5 presents our conclusions.
Background: The Changing Demography of Drug Misuse
The dynamics of drug-related incarceration in the United States should be examined in light of broader societal trends in drug use and dependence over the last forty years. The characteristics of the drug using population, particularly those dependent on expensive drugs, has changed in ways that complicate the task of keeping criminally active drug users out of prison.
Drug Epidemics
The nation has experienced four major drug-specifi c epidemics in that period; heroin (ca. 1968 to 1973), cocaine powder (ca. 1975 to 1985) , crack cocaine (ca. 1982 to 1988), and methamphetamine (ca. 1990 to 2000) . In an epidemic process, rates of initiation rise sharply as new and socially contagious users of a drug initiate friends and peers, a model fi rst well developed by Hunt and Chambers (1976) .
In the case of heroin, there is much evidence of a sudden elevation of initiation rates during the late 1960s and early 1970s, followed by a rapid incidence decline over the 1970s and 1980s (Kozel and Adams 1986; Rocheleau and Boyum 1994) . A study of an early 1990s sample of street heroin users also found evidence of sharply peaked initiation rates in the late 1960s and early 1970s. For cocaine powder the rise was similarly rapid but decline was not so pronounced as with heroin (Everingham and Rydell 1994) . For crack cocaine the epidemic was still later, starting between about 1982 and 1986, depending on the city (Cork 1999) . Caulkins et al. (2004) reported estimates of annual cocaine initiation using the National Household Survey on Drug Abuse (NHSDA) and a variety of methods; all show a peak in 1980 followed by a decline of two-thirds in the next fi ve years.
A new class of epidemiologic models has been developed by Caulkins and collaborators Caulkins 2007) , which use diverse data to document the long trajectory of drug epidemics. After the peak, the initiation rate does not return to its original zero level but falls to a rate well below the peak. Under reasonable assumptions, the result is a fl ow of new users who do not fully replace those lost through desistance, death, or incarceration. Thus, the number of active users declines gradually over time. Moreover, the drug-using population ages with corresponding changes in the health, employment, and crime consequences of substance use.
Some evidence for this characterization can be seen in the changing characteristics of drug users in TEDS (the Treatment Episode Data System) that includes data on admissions to treatment programs that receive federal funds. We do not report changes in the National Household Survey on Drug Abuse/ National Survey on Drug Use and Health (NHSDA/ NSDUH) because these include so few dependent users.
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For TEDS we are able to compare the admission cohort of 1992 with that of 2006; these two years are the earliest and latest for which detailed data are available. By 1992 all but the methamphetamine epidemics had run their courses but the cocaine and crack epidemics were relatively recent, so many of the users showing up for treatment were still young adults. Figure  3 .1, computed using 1992 and 2006 TEDS data, displays changes in the age distribution of adult clients admitted into substance abuse treatment who reported cocaine-related disorders.
In the 1992 data, 40 percent of clients were under the age of thirty. By 2006, that fi gure had dropped to 26 percent. The fraction of clients over the age of forty rose from 15 percent to 47 percent over the same period. This was not the consequence of an epidemic of new use among older individuals; rather, it represented the aging of those who were caught in the earlier epidemics.
We observed a more complex pattern within the population of admitted heroin users. As shown in fi gure 3.2, the over-forty-fi ve population displayed a similar pattern to that found in the population of cocaine users. Yet there was also a substantial population of admitted heroin users below the age of thirty.
The Drug Abuse Warning Network (DAWN) shows similar patterns of the aging of cocaine and heroin users appearing in emergency departments or as overdoses examined by medical examiners through 2002.
The result of this epidemiology is that the demography of drug misuse changed substantially between the early 1990s and the 2000s. The average age of drug users increased markedly, with a more diverse set of primary drugs of abuse.
These data suggest that current service utilization refl ects the long-term reverberation of specifi c epidemics of cocaine and heroin use in the United States. They also matter for the criminal justice system.
1. For example, in 2000, self-reported prevalences among NHSDA respondents imply that 1.2 million individuals had used cocaine in the previous month. By comparison, more broadbased estimates that included ADAM estimated a total of approximately two million that met the more stringent requirement of having used the drug more than eight times in the thirty days prior to the interview. The differential for heroin was similar (Boyum and Reuter 2005, 18 Figure 3 .3 presents these fi gures, which rely heavily on Arrestee Drug Abuse Monitoring (ADAM), showing a substantial decline, about one-third for each drug, over these twelve years. Both the data and the estimation methodology are weak, as indicated by the frequent adjustment in single year estimates in successive series published by the same research group over the period 1995 to 2000. For example, ONDCP's immediate preceding version of the estimates had shown an increase in heroin use in the early 1990s, followed by a rapid decline (Office of National Drug Control Policy 2000).
Some of the decline in these estimates may represent the consequence of increased incarceration, since those in prison are not eligible for the ADAM 2 That would have removed roughly 300,000 dependent cocaine and heroin users from the pool on which these estimates are based. Other trends may also account for some of the observed decline. For example, almost 200,000 injection drug users have died of HIV/ AIDS. Although these trends are important for many reasons, they account for less than one-third of the total decline (from 5.2 million in 1988 to 3.3 million in 2000). The best interpretation of the available data is that the number of individuals dependent on or abusing expensive drugs has been declining for a long period for a variety of reasons. The population of such users has aged, presumably reducing their involvement in violent crime.
Drug Treatment
Though the research has been critiqued by the National Research Council, (Manski, Pepper, and Petrie 2001) , a substantial body of evidence indi- 2. The calculation is done only for state prisoners because (a) jail inmates serve short terms on average and are eligible within the year for rearrest and ADAM inclusion, and (b) federal inmates include a large fraction of nonresident offenders. cates that substance abuse treatment is associated with large reductions in drug use and crime, especially during the period in which the individual drug user is in treatment. United States and British observational cohort studies document the strong association between treatment receipt and increased employment, improved health outcomes, and reduced criminal offending.
For example, Godfrey, Stewart, and Gossop (2004) reported two-year outcome data for 549 drug users enrolled in the British National Treatment Outcome Research Study (NTORS). Expenditures on substance abuse treatment for these individuals totaled 7.3 million British pounds. Economic valuation of treatment-associated crime reduction totaled 27.4 million pounds for the same group. A four-to fi ve-year follow-up indicated reductions in the frequency of heroin, street methadone, and benzodiazepines (Gossop et al. 2003) . Crack cocaine and alcohol use were not signifi cantly different after four-to fi ve-years from the corresponding values at intake. Analyzing the same data, Gossop et al. (2005) found substantial reductions in acquisitive, drug selling, and violent crimes. Crime reductions were associated with reduced regular heroin use, simple aging, and living in stable housing.
Similar results were observed with US data collected by the Drug Abuse Treatment Outcome Study (DATOS). Hubbard et al. (1997) reported that clients able to remain in long-term residential treatment for at least six months exhibited a 50 percent reduction in illegal activity and a 10 percent increase in full-time employment. Koenig et al. (2005) and Ettner et al. (2006) observed similar patterns among treatment clients in Cuyahoga County, Ohio, and California, respectively. Both of the latter papers reported strongly positive net benefi ts from treatment, with reductions in criminal offending accounting for the majority of the observed economic benefi t associated with treatment intervention.
Prendergast and colleagues provide one widely cited meta-analysis of these effects . These authors examined results from seventy-eight studies completed between 1965 and 1996. Twenty-fi ve of these analyses also examined crime outcomes; forty-six featured randomized study designs. These authors found that treatment was associated with reduced drug use (effect size ϭ 0.30) and reduced crime (effect size ϭ 0.13).
In examining the impact of treatment on crime, reduced substance use appeared to be the critical mediating variable, with reduced substance use inducing lower rates of acquisitive crime. The average age of participating drug users was the only signifi cant predictor of effect size, with treatment having a larger absolute impact in reducing crime among young adults (who are the most criminally active) than among older drug users.
Some of the strongest fi ndings for outpatient treatment arise in the arena of methadone maintenance therapy. For example, Amato et al. (2005) found that methadone maintenance therapy reduces criminality by as much as 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 60 percent. The fi ndings from a long-term cohort study of heroin users by Hser and colleagues fi nds similar results for a particularly recalcitrant heroin-using population (Hser et al. 2001) .
Retention and treatment outcomes among opiate users appear sensitive to specifi c quality measures (D'Aunno and Pollack 2002). For example, methadone maintenance clients were markedly more likely to remain in treatment (AOR ϭ 1.72) when methadone doses exceeded sixty mg/ day (Bao et al. 2009 ).
Many studies of opiate substitution therapy (OST) indicate a strong negative correlation between treatment engagement and retention on the one hand, and criminal offending on the other. Campbell, Deck, and Krupski (2007) examined arrest rates among Washington state opiate users. These authors found signifi cantly reduced probability of arrest among treatment participants. Burdon, Messina, and Prendergast (2004) found quite similar results among California offenders participating in prison aftercare.
Given these strong relationships, both state and federal prisons sought to increase treatment provision to drug-involved offenders (Grella et al. 2007; Taxman, Perdoni, and Harrison 2007) . Most such services are low-intensity education and counseling services, which probably have a limited impact on criminal offending or drug use. More intensive residential modalities have also been implemented in prison, with greater evidence that treatment participants achieved better outcomes than comparison group members ). However, because motivated individuals are more likely to enter and remain in treatment, many of the observed differences between treatment and comparison groups probably refl ect favorable selection into treatment.
Given the possibility-indeed the reality-of strong selection effects, randomized trials are especially important in evaluating the causal impact of treatment interventions. In one recent Australian study, Dolan et al. (2005) compared reincarceration, treatment mortality, and hepatitis C infection rates among opiate-dependent prison inmates randomly assigned to methadone maintenance and to a control group. Members of the treatment group displayed lower incidence of hepatitis C. Yet assignment to the treatment group appeared to provide little benefi t in terms of long-term treatment retention.
In several recent papers, Gordon et al. (2008) and Kinlock and colleagues examined drug and crime outcomes of 211 heroin-dependent Baltimore prisoners who were randomly assigned to methadone maintenance or a control-group counseling intervention (Kinlock et al. 2007; Kinlock et al. 2008; Kinlock et al. 2009 ). Offenders offered methadone maintenance shortly after release were signifi cantly less likely to use heroin/ cocaine or engage in criminal activity compared to those assigned to the control group.
A randomized trial by McMillan et al. (2008) yielded less favorable fi ndings. Offering opiate-dependent inmates methadone maintenance within the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 jail setting appeared to confer little benefi t absent an effective postrelease intervention.
Outside the arena of opiate substitution therapy, the strongest evaluation results arise in establishing the benefi ts of therapeutic communities. For example, McCollister et al. (2004) conducted a fi ve-year follow-up study examining the Amity in-prison therapeutic community and an accompanying Vista aftercare program for criminal offenders in southern California.
The average cost of addiction treatment over the baseline and fi ve-year follow-up period was $7,041 for the intervention group and $1,731 for the control group. However, the treatment group experienced eighty-one fewer incarceration days than was observed within the control group. This 13 percent reduction in incarceration more than offset the additional costs of the relatively intensive intervention.
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Evaluations of outpatient drug-free interventions yield more mixed results. In the case of cocaine, a meta-analysis of research on interventions aimed at dependent users of a variety of drugs, few of whom were in methadone maintenance, found that those in treatment were about 20 percent more likely to have positive outcomes with respect to criminality than those who did not enter treatment (Prendergast and Burdon 2002) . Even though most who enter treatment will relapse to drug use and/ or fail to complete their treatment, it is still true that treatment can make a large difference in the lifetime drug use and criminality of a dependent user.
These large differences in criminal offending lead to correspondingly large impacts in cost-benefi t analyses of substance abuse treatment. Substance abuse treatment is associated with many economic benefi ts. Yet crime reduction is consistently the largest single component of the economic benefi t of treatment (Dismuke et al. 2004; Sindelar et al. 2004; French et al. 2002; McCollister and French 2003) . Indeed, the economic benefi ts of treatmentassociated crime reductions are often larger than all other estimated benefi ts combined.
The economic valuation of treatment-related crime reduction frequently exceeds, by itself, the entire cost of providing substance abuse treatment. In one prominent analysis of cocaine-dependent clients, Flynn et al. (1999) examined treatment clients' self-reported crime before and after treatment, fi nding that the economic value of an associated reduction in crime far exceeded the associated treatment costs.
Such fi ndings are doubly striking because most studies in the empirical treatment literature understate the true social benefi ts associated with reduced crime. Most studies consider the tangible costs of crime-its direct costs to victims and to the health care and the criminal justice systems. The tangible cost approach provides a valuable lower bound to the benefi ts of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 crime reduction. However, such costs are a small fraction of the overall social costs of crime (Rajkumar and French 1997) . Flynn et al. (1999) cite tangible costs of $1,304 per burglary. By contrast, Cohen et al. (2004) obtain a per burglary cost estimate of $31,000 using contingent valuation methodologies that capture a broader range of crime consequences and societal preferences (Cohen et al. 2004 ).
Basu, Paltiel, and Pollack (2008) perform a (nonexperimental) prepost analysis of US treatment data from the National Treatment Improvement and Evaluation Study (NTIES) that illustrates the importance of these valuation measures. Using conservative econometric specifi cations that were biased against a fi nding of treatment effectiveness, these authors show that the monetized value of treatment-related reductions in armed robbery more than offset the cost of the entire treatment intervention. This fi nding is especially striking when one considers that less than 7 percent of NTIES respondents reported committing an armed robbery in the year before treatment admission. Moreover, only 32 percent of these robbery offenders reported ever being arrested for using a weapon or force to steal from a victim.
In terms of absolute numbers, substance abuse treatment providers serve a large and diverse population of substance users. As shown in table 3.1, the number of individuals in drug treatment for cocaine or heroin abuse has risen slightly since 1997; for example, TEDS data indicate admissions of 235,000 in 1997 for heroin, compared to 246,000 in 2005. Given that the estimated size of the population of dependent users has, if anything, shrunk, this indicates that the treatment fraction has increased. The fi gure for methamphetamine admissions almost tripled during the same period.
Drug Use and Crime
The criminally active population continues to show high rates of drug misuse, another indication that treatment has, at the population level, failed to reduce the connection between crime and drug use.
For this population, ADAM provides the major source for insights into the connection between crime and drug use. The ADAM survey includes For our purposes the more relevant comparisons are between 1986 and 2004, the era covered by the two inmate surveys we analyzed. The DUF system started collecting data in 1987 in just twenty-one cities (Wish and Gropper 1991) . More complete and consistent data are available from Washington, DC, which has collected urinalysis on all adult arrestees since 1984 and on all juvenile arrestees since 1988. The adult data (fi gure 3.4) show that the percentage of all arrestees testing positive for any drug excluding 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 marijuana declined from 73 percent in 1987 to 49 percent in 1991, with a stable trend over the following fi fteen years. For juvenile arrestees (fi gure 3.5) what is striking is how few have tested positive for any drug other than marijuana and PCP since the early 1990s; whereas in 1987 23 percent tested positive for cocaine, that fi gure has hovered around 7 percent since 1993.
Getting Offenders into Treatment
As already noted, the insight that drug treatment could reduce both crime and the demands on the criminal justice system has animated policy for a long time, not just in the United States but in other countries. For example, the United Kingdom saw a near doubling of the population in treatment between 1998 and 2006, largely as a consequence of a large variety of criminal justice diversion programs (Reuter and Stevens 2007) . We identify here just the major interventions.
Drug courts aim to use the coercive power of the criminal justice system, particularly the authority of a judge, to persuade drug-involved offenders to cease their drug use rather than face penalties for violating the terms of their release. Drug court clients are encouraged to seek treatment, and 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 continued participation in treatment may be a condition for staying out of jail. The evaluation literature, though not technically strong, has generally found positive effects on recidivism, the usual outcome measure (Belenko and Peugh 2005; Wilson, Mitchell, and MacKenzie 2006) .
Even though the drug court movement is almost twenty years old and over 2,300 separate programs have been created, (BJA Drug Court Clearinghouse Project 2009), a 2008 study estimated that only 55,000 drug-involved defendants were processed in such courts in the middle of this decade; the same study estimated that over one million such defendants entered the criminal justice system each year (Bhati, Roman, and Chalfi n 2008) . Despite the rapid expansion of drug courts, the number of defendants who pass through such programs remain relatively low.
This small number of enrollees arises from several factors. Many jurisdictions lack administrative capacity to implement drug courts at-scale. Fifty-two percent of adult drug courts responding to one survey reported they cannot accept some eligible clients due to capacity constraints (Bhati, Roman, and Chalfi n 2008) . Bhati and colleagues estimate the current number of drug court "slots" at approximately 55,000. Given this constraint, there are strong administrative and political incentives for drug courts to cream-skim by serving relatively low-risk populations most likely to achieve successful outcomes rather than high-risk populations that would experience the greatest net reduction in criminal offending from drug court interventions.
Even if such administrative capacity were available, enrollment would remain sharply constrained by current eligibility restrictions. Despite the pervasiveness of the drug treatment court model, drug courts routinely exclude most of the drug-using offenders. A 2005 survey of adult drug courts found that "only 12% of drug courts accept clients with any prior violent convictions. Individuals facing a drug charge, even if the seller is drug-dependent, are excluded in 70% of courts for felony sales and 53% of courts for misdemeanor sales. Other charges that routinely lead to exclusion include property crimes commonly associated with drug use (theft, fraud, prostitution), and current domestic violence cases (only 20% accept domestic violence cases)" (Rossman, Zweig, and Roman 2008 ). An earlier study conducted by the Government Accountability Office (1997) found that only 6 percent of drug courts accept offenders whose current conviction included a violent offense.
A study of drug courts in six Washington state counties found substantial variation in eligibility requirements (Cox et al. 2001) . In King County, for example, only defendants facing drug possession charges were eligible; whereas in Pierce County a long list of property crimes charges were also eligible. Similarly, Florida's Dade County accepts offenders with mainly possession or purchase of a controlled substance charges. Marion County stipulates that eligible offenders must be charged with nonviolent drug offenses, with Drug courts originally targeted fi rst-time offenders who were arrested for possession or selling to support their habit. Some programs, however, are expanding to include repeat offenders and a few are accepting violent offenders (Porter 2001) . Nevertheless, programs with fl exible eligibility criteria are rare. Table 3 .2 presents eligibility criteria for four drug courts in major jurisdictions.
More difficult to determine are the eligibility rules with respect to substance abuse. Bhati, Roman, and Chalfi n (2008) report that "eligibility based on drug use severity is applied inconsistently-16% of drug courts exclude those with a drug problem that is deemed too serious, while 48% reject arrestees whose problems are not severe enough. Almost 69% exclude those with co-occurring disorders. Even among eligible participants, more than half of drug courts (52%) report they cannot accept some clients who are eligible for participation due to capacity constraints" (8).
These eligibility rules seem likely to exclude most experienced users of cocaine, heroin, and methamphetamine. The few cohort studies of cocaine and heroin users (e.g., by Hser and colleagues) show that long-term users have accumulated long histories of convictions for property and violent crimes and that many-perhaps most-have co-occurring disorders or are polydrug users (Hser et al. 2001; Hser 2007; Hser et al. 2007 ). Estimating the potential effect of relaxing eligibility requirements is a major research challenge. Existing effectiveness fi ndings refl ect these tight eligibility requirements. Drug courts choose certain clients, and exclude more serious offenders, in the belief that defendants with longer and more serious criminal histories are more likely to have poor outcomes in drug courts. They may be correct; without evaluations of the effects with these other client groups, the research strategies for making projections are inherently speculative. We take this up in more detail in the chapter's conclusion.
California's Proposition 36 provides the largest instance of diversion from the criminal justice system. Under Prop 36 (formally the Substance Abuse and Crime Prevention Act (SACPA)), fi rst-or second-time drug possession arrestees with no record of violent offenses are subject to a drug abuse assessment to determine appropriate referral to a drug treatment program. Given that Prop 36 is focused on individuals early in their criminal careers, it would appear to have little prospect of reducing prison populations. Yet it appears to have had a sizable effect. For example, Ehlers and Ziedenberg (2006) argue that Prop 36 accounted for a decline in the projected California prison population. Whereas the population had been projected to increase from 162,000 to 180,000 between 2000 and 2005, the actual fi gure ended at only 164,000. Moreover, the rate of prison commitments for drug possession offenses in California fell from 80 per 100,000 on June 1, 2001 (date of implementation) to 57 per 100,000 four years later.
The state has funded a series of detailed evaluations of the effects of Prop 36 (Urada et al. 2008 ; University of California, Los Angeles Integrated Substance Abuse Programs 2007). A forty-two-month follow-up of the fi rst wave of Prop 36 arrestees found that the measure substantially reduced the levels of jail and prison incarceration of eligible Prop 36 offenders. The comparison was made between those deemed eligible for Prop 36 in the year before enactment and those who were eligible under Prop 36 in its fi rst year. For state prisons, it appears that offenders who would have been eligible for sentencing under Prop 36 prior to its passage spent 100 days in state prison, whereas those who were sentenced under Prop 36 terms spent only about sixty days in prison. 5 For county jails, the fi gures were similar; the average length of 5. This is based on dividing the estimated state prison costs provided in the report by the reported daily cost of a prison stay . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 time in jail over forty-two months fell from approximately ninety-fi ve days to sixty-fi ve days. 6 The evaluations do not provide information on how much of that difference was accounted for by the initial incarceration spell, and how much was due to subsequences differences in reincarceration.
Almost three quarters of those who were processed under SACPA entered treatment. Substantial fractions drop out at various points in the process. The end result is that only one-third (one quarter of the initial intake) were discharged as having completed treatment. That fi gure is consistent with other studies of outcomes of treatment episodes resulting from criminal justice referrals. Given that Prop 36 clients are under much less threat of reincarceration than those entering through drug court referrals, for example, this is a surprising and encouraging fi nding, though it underscores the challenge of retaining criminally active populations in treatment interventions.
The Prop 36 population has some unexpected characteristics. For example, though this option is only available for fi rst or second convictions on drug possession charges, it is a relatively old population with an average age of 34.8 years. Half have never entered treatment before. A substantial percentage have lengthy criminal records, even though this cannot include conviction for a violent offense.
Perhaps the inclusion of parolees among Prop 36 eligibles is an important source of the reduction in the prison and jail populations. However, only 13 percent of the clients in the most recent year of the evaluation entered from parole, and that fi gure had been as low as 8 percent in the fi rst year of the program.
Over half of those sentenced under Prop 36 were charged with possession of methamphetamine, a drug associated with high levels of criminality. However, ADAM data show a low prevalence of methamphetamine in most US cities (Office of National Drug Control Policy 2009), so the California reductions in incarceration may not generalize to other states.
On their face, the Proposition 36 fi ndings are more encouraging than drug courts as a method for reducing drug-related incarceration at the population level. The California assessments consistently suggest that the use of noncriminal penalties has not produced increases in crime rates, either as a result of higher recidivism or of reduced deterrence. Though high-risk arrestees, primarily those with many prior arrests, fare less well than others, treatment-oriented diversion aimed at nonmarijuana possession arrestees may generate a meaningful reduction in total incarceration. There are, however, some concerns that the state-sponsored evaluation, which is complex and not always clear, does not capture all the problems of implementation. For example, Hawken presents an analysis that fi nds that at the thirty-6. The report does not offer a fi gure for the cost of a day in jail; these calculations assume that it is $62.50, a fi gure cited by Ehlers and Zeidenberg (2006) . Ehlers and Zeidenberg estimate the number of jail days saved per client per year to be approximately twelve, which is roughly consistent with the thirty days estimated in the above calculation. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 month mark, arrests for all groups of Prop 36 arrestees (treatment completers, treatment dropouts, and treatment refusers) are higher than for the control group (Hawken 2009) .
Coerced abstinence/ mandatory desistence, a twenty-year crusade by UCLA's Mark Kleiman (Kleiman 2009; Kleiman 1997; Kleiman and Hawken 2008) , is a program that takes advantage of simple fi ndings from behavioral economics, psychology, and public policy. A large number of offenders are under community supervision at any one time, whether it be pretrial release, probation, or parole. Because they have been arrested or convicted, the government can subject these individuals to random drug tests and indeed does from time to time.
Coerced abstinence involves making sanctions certain, immediate, and relatively mild rather than (as is normally the case) random, delayed, and severe. Such interventions have not received widespread evaluation. The small number of existing studies have found that such programs have the predicted effects on recidivism (Harrell, Cavanagh, and Roman 1998) . So far, there have been no efforts to implement them on a large scale.
Recently, Hawaii's Opportunity Probation with Enforcement (HOPE) program has implemented the approach for the entire probation population. The results of a random assignment evaluation (Kleiman and Hawken 2008; Hawken and Kleiman 2009 ) have been very promising. Very few of those enrolled in the program fail more than twice and the recidivism rates have been dramatically lower than for the probation population previously. For example, only 21 percent of HOPE subjects were rearrested in the twelvemonth evaluation window, compared to 46 percent among those on routine probation conditions (Hawken and Kleiman 2009) .
These results and a clear articulation of the theory underlying the model by Mark Kleiman and others have given this intervention a great deal of political and professional prominence. HOPE-like experiments are being launched in a number of states. It offers the prospect of a large-scale intervention that could be implemented relatively rapidly and without requiring the development of a new expertise in the probation community.
However, for those interested in promoting drug treatment as a major intervention to reduce the incarcerated population, it is striking that coerced abstinence does not necessarily involve treatment. Probation officers want their clients to desist from drug use, and this program gives them the tools to motivate and monitor abstinence. Many drug-involved offenders do not satisfy screening criteria for actual dependence. It is unclear that many of the successful clients entered drug treatment programs or that these individuals needed such services. The adverse consequences of a failed urine test have been enough to generate abstinence. Whether abstinence will continue postsupervision is an open question but in making a judgment about the utility of coerced abstinence, it is important to note that relapse is the common experience posttreatment . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 The HOPE evaluation involved experienced offenders at risk of jail or prison. Probationers assigned to HOPE were signifi cantly less likely to produce positive drug tests or to be arrested over a twelve-month study period. These offenders spent about one-half as many days in prison on revocations or new convictions. (See table 3 .3, reproduced from Hawken and Kleiman 2009.) If HOPE were implemented on a wide scale, it might cut prison time substantially.
Incarceration and Drug Courts
This section presents a new analysis of data on the incarcerated population, including both state prisons and local jails. First, we show that offenders with drug use problems continue to be a large share of those in jail and prison, and that recent entering cohorts of drug-using inmates are considerably older on average than late-1980s cohorts. Second, we assess whether under the usual eligibility rules, an expansion of drug courts could substantially reduce the numbers of drug users locked up.
Data and Analytic Framework
We analyzed two waves of data each from the Survey of Inmates in State Correctional Facilities (SISCF) and the Survey of Inmates in Local Jails (SILJ), comparing changes in the standing local jail and state prison populations from the latter part of the 1980s to the early part of the 2000s. Specifically, the prison data are drawn from the 1986 and 2004 waves of the SISCF, and the jail data are drawn from the 1989 and 2002 waves of the SILJ. For the prison population, our analyses focus only on state inmates since the federal inmate survey was only added in 1997. Moreover, federal prisons account for fewer than 10 percent of all those incarcerated on any given day.
In both surveys, all data, including key indicators on prior offenses and on substance use, are based on inmate self-report. There is a substantial literature on such self-reporting in correctional settings both for criminal involvement (Horney and Marshall 1992) and substance use (Farabee and Fredlund 1996) ; this research suggests that the self-report methodology is a valuable data collection approach that provides an acceptable level of accuracy for both domains. The nationally representative inmate surveys employ a stratifi ed two-stage sampling design, fi rst selecting facilities and then inmates within the selected facilities. Total response rates across the four surveys ranged between 84 percent and 92 percent. As shown in table 3.4, the late 1980s prison and jail surveys completed interviews with more than 19,000 inmates, generalizing to a standing incarcerated population of roughly 846,000. In comparison, the early 2000s prison and jail surveys completed interviews with more than 21,000 inmates, generalizing to a standing incarcerated population of about 1.86 million.
For purposes of our analyses, we focus on the past-year admission cohort of convicted inmates. Prior cross-period analyses of the inmate surveys (Mumola and Karberg 2006; Belenko et al. 2002) have made comparisons for the entire incarcerated populations. Since many inmates at each survey were incarcerated long before the survey itself, indeed were potential participants in an earlier wave, comparisons of the total stock population do not describe well the changing dynamics of incarceration. Thus we identify in each case an admission cohort of newly incarcerated offenders consisting of those inmates who entered prison or jail in the twelve months preceding the date of their interview. 7 The resulting sample sizes and reference populations used for the present study are also presented in table 3.4. All analyses were performed using Stata 11.0, with reported estimates weighted to account for the complex survey design. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 
Measuring Drug Misuse
We examined changes among inmate populations in the problematic use of heroin, cocaine, and methamphetamine. For each substance, we operationalized drug abuse as self-reported daily or near-daily use in the month prior to arrest. We also defi ned cocaine to include both powder and crack cocaine, and methamphetamine to include the more general class of amphetamines.
8 Other possible indicators were less valid measures of drug abuse (e.g., any drug use in the month prior to arrest, intoxication at the time of the offense) or were entirely incommensurate across survey years (e.g., substance abuse and/ or dependence).
Results

Drug Misuse Among the Newly Incarcerated
Our fi rst fi nding is that frequent drug use continues to be prevalent among recent entering inmate cohorts. Indeed, the percentage of newly incarcerated prison and jail inmates who reported daily or near-daily use of any of the three drugs increased by one quarter and one-fi fth, respectively, between the 1980s and the 2000s. In absolute numbers, this amounts to an overall increase of roughly 129,000 convicted, drug-using offenders entering prison or jail. Of note, this increase appears to be exclusively driven by the rise in methamphetamine use, as the share of heroin and cocaine users declined slightly to moderately across the two periods.
The Changing Age-by-Drug Distributions of the Newly Incarcerated
To capture the changing age profi les of drug-involved offenders, we compared the age distributions of newly incarcerated drug-using inmates for the 1986 and 2004 prison surveys and the 1989 and 2002 jail surveys. Again, by newly incarcerated, we mean admitted to prison within the past year; and by drug abuse, we mean daily or near-daily use in the month prior to arrest. Figures 3.6, 3 .7, and 3.8 compare the age group distributions (in fi ve-year increments) for cocaine, heroin, and methamphetamine, respectively.
As shown in fi gure 3.6, the cocaine-using cohorts aged considerably between the 1980s and 2000s. Refl ecting a seven-year increase in the median age from twenty-seven to thirty-four, just 12.1 percent of newly incarcerated cocaine-abusing prison inmates were thirty-fi ve or older in 1986 compared to 47. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 median age (twenty-seven to thirty-six) and proportion of those thirty-fi ve or older (17.0 percent to 56.4 percent) were found between 1989 and 2002.
As shown in fi gure 3.7, we found sizable but relatively smaller increases in population aging across the heroin-using cohorts, with equivalent fouryear increases in the median ages of both newly incarcerated prison (thirty to thirty-four) and jail (thirty-two to thirty-six) inmates. Examining the age distributions, we found that the percentage of newly incarcerated heroinabusing prison inmates who were thirty-fi ve or older increased from roughly one quarter to one-half (25.6 percent to 48.7 percent) between 1986 and 2004. A comparable percentage point increase (from 38.6 percent to 57.2 percent) in those thirty-fi ve or older occurred among the heroin-abusing jail cohort. Of note, however, there was considerable parity across all survey years in the proportion of young (i.e., under twenty-fi ve) heroin abusers. 18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 For methamphetamine abusers, the median age rose from twenty-six to thirty among entering prison inmates and from twenty-eight to thirty-one among entering jail inmates. In the late 1980s, just 8.0 percent and 11.0 percent of newly incarcerated methamphetamine-abusing prison and jail inmates, respectively, were thirty-fi ve or older (see fi gure 3.8). By the 2000s, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 one-third or more of incoming methamphetamine-abusing prison (32.9 percent) and jail (36.0 percent) inmates exceeded this age.
The remainder of the inmate cohorts-that is, new entrants who did not report daily or near-daily use of any of the three expensive drugs in the month before arrest-showed much smaller aging patterns across survey years (see fi gure 3.9). Median ages for entering cohorts of prison and jail inmates rose three and two years, respectively. In addition, unlike the drugabusing inmates, the age distributions of the two nondrug-abusing cohorts were virtually similar across time.
The shifting age distribution of drug-involved offenders is especially important given the declining age profi le of violent offenses in this population. The probability that offenders will satisfy criteria that disqualify them from diversion programs increases with age, even as the probability of violent offending declines.
The implications of these age patterns are shown below in fi gure 3.10. Roughly one in four entering inmates below the age of twenty-fi ve were sentenced for a violent offense, a percentage that steadily declined with age. Yet older offenders were markedly more likely to be labeled habitual offenders or to face sentencing enhancements that would exclude them from typical drug diversion programs. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43 44
Drug Court Calculations
In addition to examining age distributions, we examined the proportion of incoming prisoners with problematic drug use who would be eligible for drug court diversion.
We classifi ed inmates-fi rst with the entering cohort and then with the entire incarcerated population-by characteristics that affect eligibility for drug courts. In table 3.6, those characteristics that frequently disqualify the individual for drug court are italicized; those that make individuals likely candidates are in plain text.
As shown in table 3.6, virtually all newly incarcerated inmates are likely to be deemed ineligible for drug court intervention. Results are even sharper within the entire (not just the newly incarcerated) population of druginvolved state prison inmates, as shown in table 3.7. Authors' calculations indicate that more than 85 percent have current or past sentences for a serious felony or a gun violation. Nonincident inmates are twice as likely as incident inmates to be serving current sentences for violent offenses.
This pattern illustrates a point that arises in many contexts from unemployment to welfare reform. The stock population of incarcerated offenders are a "length-biased" sample. Compared with new entrants to prison in a given year, incarcerated offenders are more likely to be long-term offenders in the midst of long incarceration spells, and are more likely to satisfy other criteria of serious offending. As in the case of welfare cash assistance (Ellwood 1989) , new entrants to prison/ temporary assistance for needy 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 families (TANF) are a distinct population from those who are long-term prisoners/ welfare recipients. Thus, programs that signifi cantly affect the fl ow of new prison entrants may have a much more modest impact on the stock of incarcerated prisoners. We return to this point in the Conclusions section.
The patterns in table 3.7 illustrate the central challenge in reducing the To put these numbers into perspective, we compared our descriptive statistics with the 2005 Treatment Episode Data System (TEDS), an administrative data set that captures at least 80 percent of all known treatment admissions in the United States in 2004. The TEDS data yield 680,775 treatment admissions for which cocaine, amphetamine, or heroin was the primary substance of misuse. The incarcerated drug-dependent populations in prisons and jails rival the substance abuse treatment system in the size of the drug-using population receiving services on any given day.
Yet only a small minority of inmates are likely to be eligible for drug courts or similar interventions. Among newly incarcerated inmates, approximately one-fi fth were under a current sentence for minor (that is, nontrafficking) drug offenses-the archetypal offense promoted as suitable for drug court intervention. An even smaller fraction were incarcerated for such crimes and had no current or prior record for disqualifying offenses. Minor drug offenders account for an even smaller fraction of the overall state prison population.
If one broadens the universe from minor drug crimes to include other offenses, diversion programs would have a slightly larger population to draw from. Approximately one-fi fth of inmates reported no history or current sentences for serious felonies.
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Perhaps our most surprising descriptive fi ndings concerned inmates in local jails. Based on our 2002 data, a very small fraction of sentenced jail inmates would be eligible for drug courts based on the eligibility criteria cited previously.
Prior criminal history factors exclude the largest share of offenders with current drug problems from drug court eligibility. More than 70 percent of heroin, cocaine, and methamphetamine users would be drug court ineligible on the basis of being under criminal justice supervision at the time of arrest or of being a habitual offender. Virtually none of these inmates would be eligible for drug courts that applied every common exclusionary criterion. Setting aside important considerations of program capacity, this suggests that relaxing eligibility criteria, especially for offenders with active or long criminal histories, would expand the pool of criminal offenders eligible for drug court and related interventions.
10. Homicide, manslaughter, kidnapping, armed robbery, unarmed robbery, burglary, aggravated assault, assault on a police officer, arson, blackmail, extortion, sex crimes, drug trafficking, other violent crimes. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 
Conclusion
We began this chapter by noting that diverting drug-involved offenders from the criminal justice system, in particular getting them into treatment rather than jail or prison, has long been a major concern of the criminal justice system. The drug court movement has been a prominent and important innovation, almost universally praised by policymakers at every level of the criminal justice system. Other innovations, such as Proposition 36 in California and intensive supervision probation in various jurisdictions have pursued the same goal.
Notwithstanding that, we have documented that the numbers of druginvolved individuals in the US state prison and local jail systems have risen substantially in the last twenty years, both in absolute numbers and as a percentage of the total. When we confi ne comparisons to those entering the prison system or jails de novo (our incident cohort) during the 1980s and after the year 2000, we see evidence that the entering drug-involved inmates are aging for the three drugs (cocaine, heroin, and methamphetamine) in contrast to a much slighter increase in the age of those not involved with drugs.
Prior studies, in particularly Bhati, Roman, and Chalfi n (2008) , have shown that drug courts have made little difference to the criminal justice system because they handle such small numbers of criminal defendants. Our chapter adds to these fi ndings with the observation that drug courts, as currently structured, have little potential to make a difference to incarceration totals because so few of those entering jail or prison would meet the eligibility requirements of the current courts.
This importantly refl ects the observed aging of the populations involved with the three drugs we examined. A large share of drug-involved offenders entering correctional facilities have accumulated long criminal careers that make them unattractive clients for the drug court movement. It is especially discouraging that this statement applies to inmates in local jails, as well as state prisons.
Ironically, the aging of the drug-using offenders has another consequence. They are now much less likely to be convicted of a new violent offense, the principal public concern about criminal offenders under community su pervision. There has been growing interest in the time to "redemption" for those with a criminal history, that is, the number of years after an arrest or conviction at which an individual is no longer much more likely to commit a new offense than someone who has never been arrested/ convicted (Blumstein and Nakamura 2009) . The policy question for drug courts is whether it is possible that a more careful analysis of the criminal careers of long-term drug users will allow the selection of some candidates for diversion programs with acceptable risks of committing a serious crime while under the super vision of a drug court or intensive probation.
Our results suggest other potential insights for policy. Reducing prison 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44 populations by diverting drug-involved offenders before incarceration seems more difficult than one might suspect. If diversion is unexpectedly difficult at the front end, other strategies may prove more effective. Greater attention and focus on the drug problems of recently released offenders, parolees, and probationers seems especially fruitful. The results of Proposition 36 are intriguing. Though it is a well-known innovation, we are unaware of any study that has examined its potential to reduce prison and jail populations if taken up nationally.
Mandated desistence programs such as the Hawaii HOPE program yield impressive early results. These seem especially promising for individuals who abuse alcohol or illicit substances, but who may not be dependent or who use substances for which available substance abuse treatment appears relatively ineffective.
For opiate-dependent offenders, strengthening the immediate linkages into postrelease opioid maintenance treatment also appears promising. Similar linkages of drug-involved offenders into long-term residential treatment and therapeutic communities also appear to be associated with reduced rates of subsequent reoffending.
Finally, more effective treatment interventions for young drug users who are not under criminal justice supervision appears especially promising. Young men receiving substance abuse treatment services display strikingly higher rates of criminal offending, particularly violent offending, than do others involved in the treatment system. Some of these young men present to the treatment system under implicit or explicit pressure from the criminal justice system. Others seek services for other reasons.
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